Multicenter study of pegylated liposomal
β
Uwe Wollina; Reinhard Dummer; Norbert H. Brockmeyer; Helga Konrad; J.-O. Busch;
π
Article
π
2003
π
John Wiley and Sons
π
English
β 96 KB
## Abstract ## BACKGROUND In single center studies and case reports, it was shown that pegylated liposomal doxorubicin (PEGβDOXO) was effective as secondβline therapy for patients with cutaneous Tβcell lymphoma (CTCL). The objective of this study was to evaluate the efficacy and toxicity of single